DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVAX (Q2019359)

From EU Knowledge Graph
Revision as of 21:08, 22 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations)
Jump to navigation Jump to search
Project Q2019359 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVAX
Project Q2019359 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    565,360.84 Euro
    0 references
    budget
    761,887.32 Euro
    0 references
    co-financing rate
    74.21 percent
    0 references
    start time
    1 November 2016
    0 references
    expected end time
    31 December 2018
    0 references
    beneficiary name (string)
    GENOMIX4LIFE SRL
    0 references
    beneficiary
    Q277381 (Deleted Item)
    0 references
    coordinate location

    40°44'48.98"N, 14°46'11.96"E
    0 references
    summary
    BIOTECNOLOGIE (Italian)
    0 references
    BIOTECHNOLOGY (English)
    0 references
    BIOTECHNOLOGIE (French)
    point in time
    14 December 2021
    0 references
    BIOTECHNOLOGIE (Dutch)
    point in time
    22 December 2021
    0 references

    Identifiers

    Italian Unique Project Code
    B18I17000200008
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2019359&oldid=20931747"